AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
Scope & Guideline
Enhancing clinical outcomes through impactful research.
Introduction
Aims and Scopes
- Respiratory Diseases:
The journal addresses a wide range of respiratory diseases, including asthma, chronic obstructive pulmonary disease (COPD), interstitial lung disease, and pulmonary hypertension, emphasizing both clinical and molecular research. - Critical Care Medicine:
The focus extends to critical care medicine, particularly the management of patients with acute respiratory distress syndrome (ARDS), sepsis, and other critical conditions, highlighting advancements in intensive care practices. - Molecular and Cellular Biology:
Research published in the journal often explores the underlying molecular and cellular mechanisms of lung diseases, including studies on gene expression, inflammation, and immune response. - Innovative Therapeutic Approaches:
The journal features studies on novel therapeutic strategies, including pharmacological interventions, biologics, and emerging therapies for various pulmonary conditions. - Public Health and Epidemiology:
The journal also emphasizes public health issues related to respiratory diseases, including studies on the impact of environmental factors, tobacco use, and healthcare disparities. - Patient-Centered Research:
There is a strong focus on patient-reported outcomes and quality of life, aiming to integrate patient perspectives into research and clinical care.
Trending and Emerging
- Personalized Medicine:
Emerging research focuses on tailoring treatments based on genetic, environmental, and lifestyle factors, particularly in conditions like asthma and pulmonary fibrosis, emphasizing the importance of individualized patient care. - Telemedicine and Remote Monitoring:
The COVID-19 pandemic has accelerated the adoption of telemedicine and remote patient monitoring technologies, leading to an increase in studies evaluating their effectiveness in managing chronic respiratory diseases. - Long-COVID and Post-Acute Sequelae:
There is growing attention on the long-term effects of COVID-19, including post-acute sequelae, with research exploring respiratory, cardiovascular, and neurological implications, highlighting the need for comprehensive care strategies. - Microbiome Research:
Increasing interest in the role of the lung microbiome in health and disease, particularly its impact on asthma, COPD, and pulmonary infections, is emerging as a significant area of research. - Innovations in Imaging Techniques:
Advancements in imaging technologies, such as machine learning applications in radiology and novel imaging biomarkers, are gaining prominence for their potential to enhance diagnosis and monitoring of lung diseases. - Environmental and Social Determinants of Health:
Research increasingly emphasizes the impact of environmental factors and social determinants on respiratory health, focusing on disparities and the need for community-based interventions.
Declining or Waning
- Traditional Diagnostic Methods:
There appears to be a decreasing emphasis on traditional diagnostic methods, such as bronchoscopies and lung biopsies, as newer, less invasive techniques and imaging modalities gain traction. - Basic Science without Clinical Correlation:
Research focusing solely on basic science without direct clinical implications or applications is becoming less prevalent, as there is a greater push for translational research that bridges laboratory findings to patient care. - General Pulmonary Rehabilitation:
While pulmonary rehabilitation remains important, there is a shift towards more specialized and targeted rehabilitation practices rather than general approaches, leading to a decline in studies focusing on broad rehabilitation protocols. - Conventional Pharmaceutical Approaches:
There is a noticeable reduction in studies promoting conventional pharmaceutical approaches, with more research being directed towards personalized medicine and biologic therapies. - Single Disease Focus:
Research that concentrates on single diseases, such as isolated studies on asthma or COPD without considering comorbidities, appears to be waning in favor of studies that examine the interplay between multiple conditions.
Similar Journals
Zeitschrift fur Pneumologie
Advancing Lung Health Through Innovative ResearchZeitschrift für Pneumologie is a pivotal journal in the field of Pulmonary and Respiratory Medicine, published by Springer Heidelberg, a renowned name in academic publishing. With its ISSN number 2731-7404, it serves as a vital platform for disseminating innovative research and clinical studies relevant to lung health and diseases. This German-based journal aims to bridge the gap between research and practice, encouraging submissions that advance knowledge in respiratory medicine, including pathophysiology, treatment modalities, and patient care strategies. Although currently categorized in the Q4 quartile within its field, its commitment to quality research and emerging insights positions it as an essential resource for researchers, healthcare professionals, and students dedicated to improving respiratory health. The journal operates within the convergence period from 2022 to 2024, promising a dynamic evolution of its content. With limited open access availability, it encourages readership and contribution from its audience, fostering a collaborative academic environment.
Journal of Critical & Intensive Care
Advancing knowledge in critical care and intensive medicine.The Journal of Critical & Intensive Care, published by the esteemed Soc Turkish Intensivists - STI, serves as a vital platform for advancing knowledge and research in the evolving fields of critical care and intensive medicine. Since its inception in 2020, this journal has focused on disseminating high-quality research that addresses the complexities and challenges faced in the intensive care units, positioning itself as a critical resource for healthcare professionals, researchers, and students in Turkey and beyond. Although currently categorized in the Q4 quartile for Critical Care and Intensive Care Medicine, with a Scopus rank of 99 out of 110, the journal is rapidly gaining attention for its scholarly contributions. With an ongoing commitment to open access principles, it aims to enhance accessibility to groundbreaking studies and reviews, promoting collaborative progress in the critical care domain. The Journal of Critical & Intensive Care is not just a publication; it is a catalyst for innovation and knowledge-sharing critical to improving patient outcomes in intensive care settings.
BMJ Open Respiratory Research
Elevating global discourse in pulmonary and respiratory research.BMJ Open Respiratory Research is a prestigious open access journal published by the BMJ Publishing Group, dedicated to advancing the field of pulmonary and respiratory medicine. Since its inception in 2014, the journal has provided a vital platform for the dissemination of innovative research and clinical findings, boasting an impressive Q1 ranking in its category as of 2023. With a Scopus rank of #35 out of 155 in Pulmonary and Respiratory Medicine, BMJ Open Respiratory Research is recognized for its high-quality content, engaging a global audience of researchers, healthcare professionals, and students. The journal embraces an open access model, ensuring that groundbreaking research is readily available to the community and stakeholders, thereby accelerating knowledge exchange and improving patient care. By focusing on diverse aspects of respiratory health, this journal plays a crucial role in shaping the future of respiratory research and practice.
Canadian Journal of Respiratory Critical Care and Sleep Medicine
Fostering collaboration for groundbreaking medical insights.Welcome to the Canadian Journal of Respiratory Critical Care and Sleep Medicine, a prestigious peer-reviewed journal published by Taylor & Francis Inc. With an ISSN of 2474-5332 and an E-ISSN of 2474-5340, this journal serves as a vital platform for disseminating cutting-edge research in the fields of critical care, intensive care medicine, and pulmonary and respiratory medicine. Since its inception in 2017, the journal has established itself within the academic community, currently holding a Q2 ranking in Critical Care and Intensive Care Medicine and a Q3 ranking in Pulmonary and Respiratory Medicine for 2023. Although it operates under a standard access model, the journal remains committed to providing valuable insights and advancing knowledge through rigorous research articles, reviews, and case studies. Positioned in the heart of the United States, the journal aims to foster collaboration and innovation among healthcare professionals, researchers, and students dedicated to enhancing respiratory care and critical treatment protocols. Join us in exploring the dynamic intersection of research and practice that defines our mission.
Respiratory Care
Exploring the Future of Respiratory Healthcare.Respiratory Care is a leading journal in the fields of Critical Care, Intensive Care Medicine, and Pulmonary and Respiratory Medicine, published by DAEDALUS ENTERPRISES INC. With a history dating back to 1973 and continuing through 2024, this journal serves as a vital platform for disseminating innovative research findings, clinical practices, and advancements in respiratory healthcare. The journal is recognized for its impact, reflected in its impressive Q2 quartile rankings across several categories in 2023, demonstrating its relevance and influence in the medical community. Although it is not an Open Access publication, it provides critical insights and foster discussions aimed at enhancing patient care and treatment protocols for respiratory diseases. The journal is indexed in notable databases, ensuring wide visibility and accessibility of its content to researchers, professionals, and students dedicated to advancing knowledge and practice in respiratory care.
Turkish Thoracic Journal
Elevating respiratory medicine with open-access discoveries.Turkish Thoracic Journal, published by AVES, is a prominent open-access platform dedicated to advancing the field of pulmonary and respiratory medicine. Since its establishment, the journal has aimed to disseminate significant research findings, clinical studies, and reviews that contribute to an improved understanding of respiratory health challenges, with a particular focus on the Turkish context and regional issues. With an E-ISSN of 2149-2530 and transitioning to open access in 2022, the journal enhances visibility and accessibility, inviting a global audience of researchers, clinicians, and students to engage with the latest scientific work. The Turkish Thoracic Journal has been indexed in major databases, although it faced a coverage discontinuation in Scopus between 2016 and 2022. Currently positioned within the 23rd percentile among its peers in the field, it invites submissions that explore innovative approaches to thoracic health, enriching the discourse in a vital area of medicine.
LUNG
Elevating respiratory medicine through rigorous research.LUNG is a prestigious academic journal that has been a cornerstone in the field of Pulmonary and Respiratory Medicine since its inception in 1959. Published by SPRINGER, the journal holds an impressive Q1 ranking in its category for 2023, reflecting its commitment to disseminating high-quality research and advancing clinical practices in respiratory health. With a Scopus rank of 24 out of 155 in its field, representing the top 16% of journals, LUNG continues to serve as a vital platform for researchers, clinicians, and students who are dedicated to addressing the complexities of lung diseases. Although currently not an open-access journal, LUNG offers valuable insights and significant contributions to the understanding of respiratory conditions, ensuring that its readership stays at the forefront of medical advancements. Researchers and professionals are encouraged to submit their work and engage with a thriving academic community that is passionate about improving patient outcomes in pulmonary health.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
Connecting scientists to the forefront of pulmonary physiology.AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, published by the American Physiological Society, stands as a prominent peer-reviewed journal dedicated to advancing the field of lung cellular and molecular physiology. With an impressive impact factor, the journal serves as a crucial platform for disseminating high-quality research focused on the intricate mechanisms underlying pulmonary function and disease. Established in 1989, this journal has consistently ranked within the top quartiles across various categories, including Q1 in Physiology and Pulmonary and Respiratory Medicine, highlighting its significance in the scientific community. The journal covers a wide scope of topics pertinent to cell biology and physiology, catering to the needs of researchers, professionals, and students seeking to explore and contribute to this vital area of study. Although currently not offering open access, it provides comprehensive access options for subscribers, ensuring that vital research is communicated effectively to the global scientific community. With a commitment to fostering innovation and inspiring future studies, the AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY remains an essential resource for those engaged in lung research.
Annals of the American Thoracic Society
Pioneering the path in pulmonary and respiratory advancements.Annals of the American Thoracic Society is a premier journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by the American Thoracic Society, this journal offers an invaluable platform for researchers and clinicians to disseminate cutting-edge research, clinical insights, and innovative methodologies. With an impressive impact factor and ranked in the top Q1 category of its field (2023) and within the top 20 of 155 according to Scopus rankings, it is positioned as a leading force in shaping clinical practice and research directions. The journal's convergence years from 2013 to 2024 indicate a commitment to providing timely and relevant content at the forefront of pulmonary health. While not an open-access journal, it ensures broad accessibility to its significant contributions in respiratory medicine, making it an essential resource for professionals, researchers, and students alike endeavoring to deepen their understanding and improve outcomes in thoracic health.
BMC Pulmonary Medicine
Empowering innovation in pulmonary medicine for a healthier tomorrow.BMC Pulmonary Medicine is a leading open access journal dedicated to the field of pulmonary and respiratory medicine, published by BMC since its inception in 2001. With an ISSN of 1471-2466, this journal plays a pivotal role in advancing knowledge and research dissemination in its field, maintaining a prominent position with a 2023 Scopus ranking of #65 out of 155 journals, placing it within the 58th percentile of the category. Based in the United Kingdom, it operates under a collaborative mission to provide unrestricted access to vital research, contributing to the global understanding of respiratory health issues. The journal is recognized for its commitment to high-quality, peer-reviewed research, as evidenced by its Q2 category designation in Pulmonary and Respiratory Medicine. BMC Pulmonary Medicine aims to foster innovation and scholarship among researchers, professionals, and students, making it an indispensable resource for anyone engaged in pulmonary research and practice. The journal, accessible to everyone, enables the dissemination of impactful research that can influence clinical practice and policy worldwide.